Biocure Technology Inc.
CUREX
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 172.00K | 146.90K | 183.30K | 230.10K | 704.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 172.00K | 146.90K | 183.30K | 230.10K | 704.60K |
| Operating Income | -172.00K | -146.90K | -183.30K | -230.10K | -704.60K |
| Income Before Tax | -203.60K | -176.30K | -175.50K | -188.70K | -2.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.20 | -0.18 | -0.18 | -0.19 | -2.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -26.80K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 2.10K |
| Net Income | -203.60K | -176.30K | -175.50K | -188.70K | -2.99M |
| EBIT | -172.00K | -146.90K | -183.30K | -230.10K | -704.60K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.02 | -0.01 | -0.01 | -0.02 | -0.33 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.05 |
| EPS Diluted | -0.02 | -0.01 | -0.01 | -0.02 | -0.33 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.05 |
| Average Basic Shares Outstanding | 51.13M | 116.63M | 114.93M | 114.93M | 111.54M |
| Average Diluted Shares Outstanding | 51.13M | 116.63M | 114.93M | 114.93M | 111.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |